The 7th Annual Breast Cancer Update: Screening, Diagnosis and Current Treatment Friday, November 6, 2009 Marriott Waterfront Hotel Continuing Medical Education Information CME Sponsorship This educational activity is sponsored by the University of Maryland School of Medicine. Overview Breast cancer is the most common cancer among women in the United States, with an estimated 180,000 new cases diagnoses annually. A multidisciplinary focus that entails prevention, diagnosis, and treatment has led to significant strides in the reduction of breast cancer incidence and mortality. Additionally, breast cancer management has become increasingly complex, requiring comprehensive assessment and review of multiple issues that include the role of genetic testing, imaging and breast magnetic resonance imaging, surgical and reconstructive options, and a variety of new adjuvant therapies. Target Audience This educational activity is intended for physicians and allied health care personnel, including primary care physicians, general surgeons, medical oncologists, radiation oncologists, radiologists, nurse practitioners with an interest on the multidisciplinary approach to diagnosis and treatment of breast cancer. Learning Objectives Upon completion of this activity, participants should be able to describe and discuss: • The comprehensive multidisciplinary approach to the evaluation and treatment of breast cancer patients. • Treatment recommendations for stages 13 of breast cancer. • Recommendations for genetic evaluation and testing. • Screening methods for breast cancer, including the role of MRI and ultrasound. • Implications of positive / abnormal mammograms. • New surgical techniques in breast reconstruction. • Programs and resources for breast cancer survivorship and support. Accreditation The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation The University of Maryland School of Medicine designates this educational activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control activity content of continuing medical education activities must disclose their financial relationships with commercial interests relevant
1
to the content of the CME activity. Any conflicts of interest identified must be resolved prior to presentation of the educational activity.
The following individuals have disclosed no relevant financial relationships with commercial interests:
Ting Bao, M.D., DABMA Robert R. Buras, M.D., F.A.C.S. Cristina Campassi, M.D. Saranya Chumsri, M.D. Anil A. Dhople, M.D.
Amy M. Fulton, Ph.D. Olga B. Ioffe, M.D. Eduardo D. Rodriguez, M.D., D.D.S. Jessica E. Rispoli Joines, M.G.C., C.G.C. Katherine H. Rak Tkaczuk, M.D.
Discussion of OffLabel or Investigational Uses Presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. The audience is advised to consult the full prescribing information of all drugs or devices prior to use. Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law. UMSOM requires that all contributors disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients. Disclaimer This CME activity is designed for use by healthcare professionals for educational purposes only. Information and opinions offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDAapproved uses and information. While UMSOM makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decisionmaking before applying any information, whether provided here or by others. Acknowledgement of Support The following institutions, organizations, and/or companies have provided educational grants in support of the 7th Annual Breast Cancer Update: Genentech
2